Ligand Pharmaceuticals Incorporated (LGND) vs Praxis Precision Medicines, Inc. (PRAX)

• Ligand Pharmaceuticals Incorporated LGND 295.54 ▼ −0.99%
• Praxis Precision Medicines, Inc. PRAX 241.76 ▼ −2.61%

Ligand Pharmaceuticals Incorporated and Praxis Precision Medicines, Inc. are both Biotechnology companies. Praxis Precision Medicines, Inc. is the larger, with a market value of $6.9B against $6.0B — 1.2× the size. Praxis Precision Medicines, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 29.5×. Praxis Precision Medicines, Inc. grew revenue faster over the last twelve months: 249.5% against 54.9%. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs 0.00%) and the higher return on invested capital (8.19% vs −40.6%). Across the 17 metrics below, Ligand Pharmaceuticals Incorporated leads on 13 and Praxis Precision Medicines, Inc. on 4.